Success Story: NIW Approval for an Infectious Diseases Physician Driving Evidence-Based Practice Across the U.S. Health Systems
Client’s Testimonial:
“The process was streamlined with a good understanding of creating a dossier that matches the needs of the national interest waiver, with support digitally and over the phone as needed. Overall, a positive experience with a positive result.”
On January 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Medical Director / Associate Professor in the Field of Infectious Diseases (Approval Notice).
General Field: Infectious Diseases
Position at the Time of Case Filing: Infectious Diseases Physician, Medical Director / Associate Professor
Country of Origin: Canada
Country of Residence at the Time of Filing: Canada
Approval Notice Date: January 23rd, 2026
Processing Time: 3 months, 6 days (Premium Processing Requested)
Case Summary:
This NIW case featured an infectious diseases physician and medical leader whose proposed endeavor centers on one of the most durable national needs in public health: generating rigorous evidence that improves how the United States prevents, diagnoses, and manages emerging and complex infectious diseases.
North America Immigration Law Group (Chen Immigration Law Associates) framed the endeavor as health-system infrastructure: evidence that can guide infection prevention, inform treatment decisions, and improve readiness for the next complex outbreak or healthcare-associated threat. This approach helped present the endeavor as substantial in merit and national in importance because it supports safer care environments and a more effective public health response.
Well Positioned: A Record of High-Impact Scholarship
The case also showed clear momentum and professional standing. The client documented research results in:
- 46 peer-reviewed journal articles (13 first-authored)
- 6 abstracts (2 first-authored)
- 4 technical reports
- 1,322 citations to the published body of work
The record supported that the client’s work has clear relevance to infection control decision-making and policy development, especially where healthcare systems must balance effectiveness, feasibility, and safety for both patients and professionals.
One expert captured that practical impact directly:
"Overall, [Client]’s role in generating evidence for infection control policies is essential for protecting the health of both professionals and patients. "
The ResultThe approval reflected a well-supported showing of national importance and a strong record demonstrating that the client is well-positioned to continue advancing evidence-based infectious disease practice and public health strategy in the United States. We are honored to have assisted our client in achieving this NIW approval, and we congratulate them on this important milestone.